Blog
Planify news
MedGenome, backed by Sequoia Capital, acquires Delhi-NCR based Prognosis Laboratories
  • MedGenome, backed by Sequoia Capital, acquires Delhi-NCR based Prognosis Laboratories

    26 May 2023

    MedGenome on Friday acquired Delhi-NCR-based diagnostic lab Prognosis Laboratories. The financial details of the acquisition were not disclosed. The acquisition will help Bengaluru-based MedGenome to accelerate growth and geographic penetration. "The transaction augments MedGemone's comprehensive diagnostic portfolio, a foothold in Northern India, coupled with complementary business models and natural synergies to drive growth and profitability," Medgenome said in a statement.

    Image

    Stay Connected, Stay Informed –

    Join Our

    WhatsApp

    Channel!

    Don’t miss out on exclusive updates, market trends, and real-time investment opportunities. Be the first to know about the latest unlisted stocks, IPO announcements, and curated Fact Sheets, delivered straight to your WhatsApp.